Cytokeratin 19-fragments (CYFRA 21-1) as a novel serum biomarker for response and survival in patients with advanced pancreatic cancer

The prognostic and predictive value of serum CA19.9 in pancreatic cancer

(2012) J. L. Humphris et al.   ANNALS OF ONCOLOGY

Predictive and prognostic value of circulating nucleosomes and serum biomarkers in patients with metastasized colorectal cancer undergoing Selective Internal Radiation Therapy

(2012) Yvonne Nadine Fahmueller et al.   BMC CANCER

EGFR pathway biomarkers in erlotinib-treated patients with advanced pancreatic cancer: translational results from the randomised, crossover phase 3 trial AIO-PK0104

(2012) S Boeck et al.   BRITISH JOURNAL OF CANCER

Cancer statistics, 2012

(2012) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Systemic treatment of advanced pancreatic cancer

(2012) Volker Heinemann et al.   CANCER TREATMENT REVIEWS

Advances in Biomarker Research for Pancreatic Cancer

(2012) Kruttika Bhat et al.   CURRENT PHARMACEUTICAL DESIGN

CYFRA 21-1 as a Prognostic and Predictive Marker in Advanced Non–Small-Cell Lung Cancer in a Prospective Trial: CALGB 150304

(2012) Martin J. Edelman et al.   Journal of Thoracic Oncology

VEGF pathway genetic variants as biomarkers of treatment outcome with bevacizumab: an analysis of data from the AViTA and AVOREN randomised trials

(2012) Diether Lambrechts et al.   LANCET ONCOLOGY

New biomarkers and targets in pancreatic cancer and their application to treatment

(2012) Eithne Costello et al.   Nature Reviews Gastroenterology & Hepatology

Pancreatic cancer

(2011) Audrey Vincent et al.   LANCET

Application of a Time-Varying Covariate Model to the Analysis of CA 19-9 as Serum Biomarker in Patients with Advanced Pancreatic Cancer

(2010) S. Boeck et al.   CLINICAL CANCER RESEARCH

Tumor markers in pancreatic cancer: a European Group on Tumor Markers (EGTM) status report

(2009) M. J. Duffy et al.   ANNALS OF ONCOLOGY

Carbohydrate antigen 19-9 change during chemotherapy for advanced pancreatic adenocarcinoma

(2009) Michele Reni et al.   CANCER

Postresection CA 19-9 Predicts Overall Survival in Patients With Pancreatic Cancer Treated With Adjuvant Chemoradiation: A Prospective Validation by RTOG 9704

(2008) Adam C. Berger et al.   JOURNAL OF CLINICAL ONCOLOGY

CA 19-9 tumour-marker response to chemotherapy in patients with advanced pancreatic cancer enrolled in a randomised controlled trial

(2008) Viviane Hess et al.   LANCET ONCOLOGY

Nucleosomes and CYFRA 21-1 indicate tumor response after one cycle of chemotherapy in recurrent non-small cell lung cancer

(2008) Stefan Holdenrieder et al.   LUNG CANCER